Meeting
2018 ASCO Annual Meeting
Overweight and breast cancer risk in the International Breast Cancer Intervention studies I and II.
Authors
Samuel G Smith
University of Leeds, Leeds, United Kingdom
Samuel G Smith , Ivana Sestak , Michelle A Morris , Anthony Howell , John F. Forbes , Jack M. Cuzick
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Clinical Trial Registration Number
ISRCTN91879928 and ISRCTN31488319
Citation
J Clin Oncol 36, 2018 (suppl; abstr 1560)
DOI
10.1200/JCO.2018.36.15_suppl.1560
Abstract #
1560
Poster Bd #
131
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Impact of body mass index (BMI) on the efficacy of zoledronic acid in premenopausal patients with hormone receptor positive breast cancer: An analysis of the ABCSG-12 trial.
First Author: Georg Pfeiler
First Author: Ji-Yeon Kim
Poster
2016 ASCO Annual Meeting
Phase II trial of CC-486, a DNA methyltransferase inhibitor, in combination with fulvestrant in postmenopausal women with ER+, HER2- metastatic breast cancer who have progressed on an aromatase inhibitor (AI).
First Author: Mario Campone
Poster
2014 Breast Cancer Symposium
Obesity and menopausal status as determinants of procarcinogenic breast inflammation.
First Author: Neil M. Iyengar